Last reviewed · How we verify
Midazolam and Dexmedetomidine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Midazolam and Dexmedetomidine (Midazolam and Dexmedetomidine) — Second Affiliated Hospital of Wenzhou Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Midazolam and Dexmedetomidine TARGET | Midazolam and Dexmedetomidine | Second Affiliated Hospital of Wenzhou Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Midazolam and Dexmedetomidine CI watch — RSS
- Midazolam and Dexmedetomidine CI watch — Atom
- Midazolam and Dexmedetomidine CI watch — JSON
- Midazolam and Dexmedetomidine alone — RSS
Cite this brief
Drug Landscape (2026). Midazolam and Dexmedetomidine — Competitive Intelligence Brief. https://druglandscape.com/ci/midazolam-and-dexmedetomidine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab